Deferasirox
Deferasirox is a prescription medication that acts as an iron chelator to remove excess iron from the body, commonly used in patients with iron overload due to blood transfusions or certain blood disorders. It comes as oral tablets in strengths of 90 mg, 180 mg, and 360 mg, manufactured by Xiromed, LLC under ANDA212995. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Deferasirox is a prescription medication that acts as an iron chelator to remove excess iron from the body, commonly used in patients with iron overload due to blood transfusions or certain blood disorders. It comes as oral tablets in strengths of 90 mg, 180 mg, and 360 mg, manufactured by Xiromed, LLC under ANDA212995. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Deferasirox",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Deferasirox — ANDA 203560 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203560"
}
]
|
| identifier | ANDA203560 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"health-care",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Deferasirox |
